REVersal of nEuromusculAr bLocking Agents in Patients Undergoing General Anaesthesia (REVEAL Study).
Massimiliano GrecoPier Francesco CarusoGiovanni AngelottiRomina AcetoGiacomo CoppaliniNicolò MartinettiMarco AlbiniLori D BashMichele CarvelloFederico PiccioniRoberta MonzaniMarco MontorsiMaurizio CecconiPublished in: Journal of clinical medicine (2023)
Unrestricted availability of sugammadex led to a considerable increase in pharmacological NMBA reversal, with rocuronium use also rising. More research is needed to determine how unrestricted and safer NMBA reversal affects anesthesia intraoperative monitoring and practice.